» Articles » PMID: 28402167

Multiinstitutional Analysis of Thyroid Nodule Risk Stratification Using the American College of Radiology Thyroid Imaging Reporting and Data System

Overview
Specialties Oncology
Radiology
Date 2017 Apr 13
PMID 28402167
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Guidelines for managing thyroid nodules are highly dependent on risk stratification based on sonographic findings. The purpose of this study is to evaluate the risk stratification system used by the American College of Radiology Thyroid Imaging Reporting and Data System (TIRADS).

Materials And Methods: Patients with thyroid nodules who underwent sonography and fine-needle aspiration were enrolled in a multiinstitutional study. The sonographic nodule features evaluated in the study were composition, echogenicity, margins, and echogenic foci. Images were reviewed by two radiologists who were blinded to the results of cytologic analysis. Nodules were assigned points for each feature, and the points were totaled to determine the final TIRADS level (TR1-TR5). The risk of cancer associated with each point total and final TIRADS level was determined.

Results: A total of 3422 nodules, 352 of which were malignant, were studied. The risk of malignancy was closely associated with the composition, echogenicity, margins, and echogenic foci of the nodules (p < 0.0001, in all cases). An increased aggregate risk of nodule malignancy was noted as the TIRADS point level increased from 0 to 10 (p < 0.0001) and as the final TIRADS level increased from TR1 to TR5 (p < 0.0001). Of the 3422 nodules, 2948 (86.1%) had risk levels that were within 1% of the TIRADS risk thresholds. Of the 474 nodules that were more than 1% outside these thresholds, 88.0% (417/474) had a risk level that was below the TIRADS threshold.

Conclusion: The aggregate risk of malignancy for nodules associated with each individual TIRADS point level (0-10) and each final TIRADS level (TR1-TR5) falls within the TIRADS risk stratification thresholds. A total of 85% of all nodules were within 1% of the specified TIRADS risk thresholds.

Citing Articles

Cancer Risk in Thyroid Nodules: An Analysis of Over 1000 Consecutive FNA Biopsies Performed in a Single Canadian Institution.

Smit E, Samadi S, Wilson M, Low G Diagnostics (Basel). 2025; 14(24.

PMID: 39767136 PMC: 11727141. DOI: 10.3390/diagnostics14242775.


Validation of ACR TI-RADS performance in transition age: results from a multicenter retrospective study by the TALENT study group.

Grani G, Stramazzo I, Locantore P, Virili C, Filardi T, Lecis C Endocrine. 2024; 87(3):1131-1140.

PMID: 39671149 DOI: 10.1007/s12020-024-04117-3.


The Horizon of Thyroid Imaging Reporting and Data System in the Diagnostic Performance of Thyroid Nodules: Clinical Application and Future Perspectives.

Sharafi S, Moarefzadeh M, Moradi M touchREV Endocrinol. 2024; 20(2):81-90.

PMID: 39526062 PMC: 11548367. DOI: 10.17925/EE.2024.20.2.11.


Thyroid Nodule Characterization: Overview and State of the Art of Diagnosis with Recent Developments, from Imaging to Molecular Diagnosis and Artificial Intelligence.

David E, Grazhdani H, Tattaresu G, Pittari A, Foti P, Palmucci S Biomedicines. 2024; 12(8).

PMID: 39200141 PMC: 11351886. DOI: 10.3390/biomedicines12081676.


Individual Ultrasonographic Characteristics of Thyroid Nodules and Their Cytopathological Correlation to Determine Malignancy Risk.

Castilla Villanueva M, Solis Cano D, Amador Martinez A, Teliz Meneses M, Baquera-Heredia J, Vallin Orozco C Cureus. 2024; 16(7):e63918.

PMID: 39105015 PMC: 11299551. DOI: 10.7759/cureus.63918.